鼻咽癌高发区正常人群血清中EB病毒补体结合抗体的滴度较非高发区为高,鼻咽癌患者血清中EB病毒补体结合抗体,无论是高滴度抗体的百分率(≥1:320)或抗体的几何平均滴度,又均较正常人和非鼻咽癌的癌症患者为高,这是已经得到实验证实了的。但是,鼻咽癌患者血清中EB病毒补体结合抗体的水平与鼻咽癌的病理组织学改变有何关系,则尚未见报告。本文就是为了研讨其间的关系而设计的。 The titers of EB virus complement-binding antibody in the serum of normal population in high-incidence regions of nasopharyngeal carcinoma were higher than those in non-high-incidence areas, and the complement of EB virus complement antibody in serum of patients with nasopharyngeal carcinoma, whether it was the percentage of high titer antibody (≥1:320) The geometric mean titer of antibodies or antibodies was higher than that of normal and non-nasopharyngeal cancer patients, which has been confirmed by experiments. However, no correlation has been reported between the level of EB virus complement-binding antibody in nasopharyngeal carcinoma patients and the histopathological changes of nasopharyngeal carcinoma. This article is designed to study the relationship between them.